strategic response by pharmaceutical firms to the Medicaid Most-Favored-Customer rules
By: Fiona Scott Morton.
Contributors: National Bureau of Economic Research.
Series: NBER working paper series -- working paper 5717; Working paper series (National Bureau of Economic Research) -- working paper no. 5717.
Publisher: National Bureau of Economic Research
Published: 1996
Place of publication: Cambridge, MA
Language: eng
Number of pages: 38
Subjects: Pharmaceutical industry -- United States -- Finance.; Drugs -- Prices -- United States.; Medicaid -- Cost control.
Notes: "August 1996."

Includes bibliographical references (p. 31-32).

Electronic access limited to Binghamton University faculty, staff and students for instructional and research purposes only.

Electronic version available via the Internet at the NBER World Wide Web site.